HIV Antiretroviral Therapy Costs in the United States, 2012-2018
Nicole C. McCann, Tim H Horn, Emily P. Hyle, Rochelle P. Walensky
Abstract
This study characterizes the costs of recommended initial HIV antiretroviral therapy regimens in the United States from 2012 to 2018 and the magnitude of cost changes over time.
Topics & Concepts
MedicineAntiretroviral therapyHuman immunodeficiency virus (HIV)ANTIRETROVIRAL AGENTSIntensive care medicineFamily medicineViral loadHIV/AIDS Research and InterventionsHIV, Drug Use, Sexual RiskHIV/AIDS drug development and treatment